Serpine 1 (plasminogen activator inhibitor-1), which correlates to body-mass index, plasma triglyceride and insulin levels, has a significant clinical value in metabolic disturbance related diseases, including atherosclerosis, type 2 diabetes, obesity and liver steatosis42, 43. Here, SERPINE1 is linked to type 2 diabetes mellitus.